AstraZeneca Falls, Ryanair Climbs, Clarkson Soars: Today’s Stock Movers

Bullish Gator

AstraZeneca plunges on reported BMS acquisition talks; Ryanair gains as fuel worries ease; Clarkson hits record high after strong H1 results—Bloomberg’s roundup of today’s biggest market winners and losers.

Editorial companion

What stands out

Bloomberg’s Stock Movers picked up on a whisper that AstraZeneca explored buying Bristol Myers Squibb (BMY), and the market responded. A deal of that scale would be one of the biggest ever in pharma, the sort of event that rearranges pipelines, R&D priorities and investor math across the sector. The clip matters because BMY’s reported fundamentals, about 1.5% average revenue growth paired with an average net income swing of -121.1% year over year, make takeover chatter both plausible and noisy, not necessarily salutary for long-term holders.